±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1003  |  »Ø¸´: 15
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yalefield

½ð³æ (ÎÄ̳¾«Ó¢)

ÀϺºÒ»Ã¶

[½»Á÷] FDA QSAR Toxicity Models Now Available

http://www.leadscope.com/fda_qsar_models/

Columbus, Ohio August 26, 2008 ¨C Leadscope announces the availability of the Leadscope FDA QSAR Toxicity Models.  

Leadscope is making the FDA QSAR Toxicity Models available through a Cooperative Research & Development Agreement with the U.S. Food & Drug Administration (FDA). These models allow scientists to predict the potential toxicity and adverse human clinical effects of pharmaceuticals, cosmetics, food ingredients and other chemicals.

The Models are constructed by FDA scientists based on both proprietary and non-proprietary data. Leadscope technology allows delivery of models without disclosing any training sets.

The FDA QSAR Toxicity Models will be distributed via annual licenses in Suites containing multiple models relative to specific biological endpoints.  The following Suites are now available:

Toxicity Endpoints                                                        Human Clinical Endpoints
▪ Rodent Carcinogenicity                                              ▪ Cardiological Adverse Effects
▪ Genetic Toxicity                                                         ▪ Hepatobiliary Adverse Effects
▪ Reproductive Toxicity                                                ▪ Urinary Tract Adverse Effects
▪ Developmental Toxicity
▪ Neurotoxicity
▪ Misc. Toxicity Endpoints

A scientist may enter a single compound or a batch of compounds and receive predictions across multiple endpoints.  The FDA QSAR Toxicity Models are a stand-alone product not requiring any other software or training.

Loftus Lucas, Leadscope¡¯s CEO, said, ¡°The release of these FDA QSAR Toxicity Models culminates several years of work with the FDA to bring their toxicity data to scientists in an easy to use system.  Scientists will get the same prediction from these Models as an FDA Regulator¡±.  

The FDA Center for Drug Evaluation and Research (CDER) Informatics and Computational Safety Analysis Staff (ICSAS) and Leadscope are pleased to host a symposium on the use of Leadscope software with FDA databases for QSAR computational toxicology safety analysis at the FDA, other U.S. government agencies and international regulatory bodies.  The all-day meeting will be held on September 17, 2008 at the new FDA White Oak Campus in Silver Spring, Maryland.  This symposium is free and open to the public.  To view the agenda visit www.leadscope.com/fda_symposium.php.  Registration is required.  Please RSVP by September 12, 2008, at info@leadscope.com.  

To view the FDA QSAR Model Suites visit Leadscope¡¯s website at www.leadscope.com/fda_qsar_models.  For further information or to request on-line demonstration with a Leadscope scientist, contact us at info@leadscope.com.

Loftus Lucas
Leadscope, Inc.

1393 Dublin Road
Columbus, Ohio 43215
Phone: 614-599-2700
Fax:  614-675-3732

info@leadscope.com
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

loappleve

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Originally posted by yalefield at 2008-8-29 19:22:


ÄúÊÇÎÊÀϺº£¿

ÄÏÈ­±±ÍÈÔ´ÉÙÁÖ
ÅÀ±ùÎÔÑ©ËÄÌåÇÚ
NÄê¹¶ÑÓÏóÑÀËþ
Ô¶¶ÉÖØÑó´ÎµÈÈË

Îﻯ¿ªÂ·ËãÄÜÁ¿
·ÖÎö×÷ÑÛ¹ÛÆ×·å
ºÏ³ÉÄËÊǼҳ£²Ë
ÎÞ»ú¾§ÌåËãÓ¦ÓÃ

ÔøÑ§FortranÍæµ½ËÀ£¨¡°µ½ËÀ¡±=DOS£¬Î¢Èí¹«Ë¾ÔçÆÚµÄ ...

ÓÖÄÃÕâÊ«À´ºýŪÈ˰¡
ÏàÐÅÎÒÃÇÓлú»á¼ûÃæ£¡
13Â¥2008-09-01 21:59:57
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 16 ¸ö»Ø´ð

dnp

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

Сľ³æÀË×Ó

ÓÅÐã°æÖ÷

ºÇºÇ£¬»¯Ñ§¼ÆÁ¿Ñ§Èí¼þ¹úÍâ·¢Õ¹µÃÔ½À´Ô½ºÃÁË£¬µ«ÊǹúÄÚÈ´ÓеãÌá²»ÉÏÆø¹þ~~
What would Jesus do?
2Â¥2008-08-27 11:46:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tjegg

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ºÃ¶«Î÷£¬Ð»Ð»Â§×¡¡£
³ýÁËÄãµÄÇ×ÈË£¬Ã»ÓÐÈËÓ¦¸Ã¶ÔÄãºÃ£¬¶ÔÄãºÃµÄÈË£¬Ò»¶¨ÒªÕäϧ¡£
3Â¥2008-08-27 21:08:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yalefield

½ð³æ (ÎÄ̳¾«Ó¢)

ÀϺºÒ»Ã¶

ÒýÓûØÌû:
Originally posted by tjegg at 2008-8-27 21:08:
ºÃ¶«Î÷£¬Ð»Ð»Â§×¡¡£

Ì«ÈÈ£¬²»Â§ÁË¡£
4Â¥2008-08-27 22:08:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á +9 0856²ÄÁÏÓ뻯¹¤3 2026-04-04 11/550 2026-04-05 05:22 by houyaoxu
[¿¼ÑÐ] 306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +6 Àè°ÉÀ²À²ÄãºÜÓÐà 2026-04-03 6/300 2026-04-04 23:59 by ¹û¶³´óÍõ
[¿¼ÑÐ] Äܶ¯µ÷¼Á326ר˶ +4 wan112233 2026-04-04 4/200 2026-04-04 22:47 by yu221
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϺ½£¬ÊýһӢһѧ˶317Çóµ÷¼Á£¡£¡ +3 Acaciad 2026-04-04 3/150 2026-04-04 22:29 by lbsjt
[¿¼ÑÐ] ²ÄÁϹ¤³Ì310ר˶µ÷¼Á +11 ÀÌÀÌÎÒ¡­. 2026-04-04 11/550 2026-04-04 22:26 by lbsjt
[¿¼ÑÐ] 081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ +15 ÅûÐÇºÓ 2026-04-03 15/750 2026-04-04 16:25 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼Á +4 ѹÁ¦??´ó 2026-04-03 4/200 2026-04-03 21:36 by à£à£à£0119
[¿¼ÑÐ] 294Çóµ÷¼Á +6 Grey_Ey 2026-04-03 6/300 2026-04-03 20:46 by ÐÀϲ777
[¿¼ÑÐ] 262Çóµ÷¼Á +6 ÀøÖ¾Ò»¶¨·¢ÎÄÕ 2026-04-02 7/350 2026-04-03 09:54 by linyelide
[¿¼ÑÐ] 346Çóµ÷¼Á +5 Ö£³ÏÀÖ 2026-04-02 5/250 2026-04-02 16:38 by SZW_UJN
[¿¼ÑÐ] 321Çóµ÷¼Á Ò»Ö¾Ô¸ Õã½­¹¤Òµ´óѧÉúÎïÒ½Ò© +5 ºÙºÙHC 2026-04-01 6/300 2026-04-02 15:23 by sophie2180
[¿¼ÑÐ] 348Çóµ÷¼Á +6 ÎâÑå׿24k 2026-04-02 6/300 2026-04-02 14:07 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] ³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ +6 axibli 2026-04-01 6/300 2026-04-02 13:42 by Ecowxq666£¡
[¿¼ÑÐ] ʳƷѧ˶362Çóµ÷¼Á +3 xuanxianxian 2026-04-01 3/150 2026-04-01 21:05 by °¡Àî999
[¿¼ÑÐ] »·¾³¹¤³Ìµ÷¼Á +9 hyzzzzzzz. 2026-04-01 9/450 2026-04-01 14:20 by salamander`
[¿¼ÑÐ] ½­ËÕËÕ±±¸ßУ³ÏÑûµ÷¼Áͬѧ +3 zzll406 2026-03-31 3/150 2026-03-31 16:54 by ¼°Ê±ÐÐÀÖfan
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +10 hyl3153942 2026-03-29 10/500 2026-03-31 16:31 by hypershenger
[»ù½ðÉêÇë] ÃæÉÏ5BÄÜÉÏ»áÂ𣿠+8 redcom 2026-03-29 8/400 2026-03-31 15:53 by niuailing
[¿¼ÑÐ] ¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤×¨Ë¶378Çóµ÷¼Á +3 Ëþ±ÈÎÚ˹ 2026-03-30 3/150 2026-03-30 22:55 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 0703»¯Ñ§321·ÖÇóµ÷¼Á +10 Èýdd. 2026-03-30 11/550 2026-03-30 19:24 by markhwc
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û